JP2014141528A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014141528A5 JP2014141528A5 JP2014095094A JP2014095094A JP2014141528A5 JP 2014141528 A5 JP2014141528 A5 JP 2014141528A5 JP 2014095094 A JP2014095094 A JP 2014095094A JP 2014095094 A JP2014095094 A JP 2014095094A JP 2014141528 A5 JP2014141528 A5 JP 2014141528A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- composition according
- vlp
- norovirus
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 30
- 229960005486 vaccine Drugs 0.000 claims 29
- 241001263478 Norovirus Species 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 239000002671 adjuvant Substances 0.000 claims 4
- 229920001661 Chitosan Polymers 0.000 claims 3
- 150000004676 glycans Chemical class 0.000 claims 3
- 229940035032 monophosphoryl lipid a Drugs 0.000 claims 3
- 230000003232 mucoadhesive effect Effects 0.000 claims 3
- 229920001282 polysaccharide Polymers 0.000 claims 3
- 239000005017 polysaccharide Substances 0.000 claims 3
- 208000006339 Caliciviridae Infections Diseases 0.000 claims 2
- 229940123384 Toll-like receptor (TLR) agonist Drugs 0.000 claims 2
- 239000000227 bioadhesive Substances 0.000 claims 2
- 229940124447 delivery agent Drugs 0.000 claims 2
- 239000002158 endotoxin Substances 0.000 claims 2
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 claims 2
- 229920006008 lipopolysaccharide Polymers 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 2
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 229920002567 Chondroitin Polymers 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 229920000045 Dermatan sulfate Polymers 0.000 claims 1
- 241000056533 Houston virus Species 0.000 claims 1
- 102000004856 Lectins Human genes 0.000 claims 1
- 108090001090 Lectins Proteins 0.000 claims 1
- 241000532183 Norovirus GI Species 0.000 claims 1
- 241000532184 Norovirus GII Species 0.000 claims 1
- 241000714209 Norwalk virus Species 0.000 claims 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 229920002125 Sokalan® Polymers 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims 1
- -1 co-chelates Polymers 0.000 claims 1
- 230000008021 deposition Effects 0.000 claims 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims 1
- 229940051593 dermatan sulfate Drugs 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000002523 lectin Substances 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 210000002850 nasal mucosa Anatomy 0.000 claims 1
- 239000001814 pectin Substances 0.000 claims 1
- 235000010987 pectin Nutrition 0.000 claims 1
- 229920001277 pectin Polymers 0.000 claims 1
- 229960000502 poloxamer Drugs 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
- 229920002627 poly(phosphazenes) Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 239000000277 virosome Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97338907P | 2007-09-18 | 2007-09-18 | |
| US60/973,389 | 2007-09-18 | ||
| US98682607P | 2007-11-09 | 2007-11-09 | |
| US60/986,826 | 2007-11-09 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525114A Division JP2010539192A (ja) | 2007-09-18 | 2008-09-18 | ノロウイルスに対して防御免疫応答を付与する方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016149168A Division JP6615063B2 (ja) | 2007-09-18 | 2016-07-29 | ノロウイルスに対して防御免疫応答を付与する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014141528A JP2014141528A (ja) | 2014-08-07 |
| JP2014141528A5 true JP2014141528A5 (https=) | 2015-06-11 |
| JP6296885B2 JP6296885B2 (ja) | 2018-03-20 |
Family
ID=40468754
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525114A Pending JP2010539192A (ja) | 2007-09-18 | 2008-09-18 | ノロウイルスに対して防御免疫応答を付与する方法 |
| JP2014095094A Active JP6296885B2 (ja) | 2007-09-18 | 2014-05-02 | ノロウイルスに対して防御免疫応答を付与する方法 |
| JP2016149168A Active JP6615063B2 (ja) | 2007-09-18 | 2016-07-29 | ノロウイルスに対して防御免疫応答を付与する方法 |
| JP2019107207A Withdrawn JP2019163328A (ja) | 2007-09-18 | 2019-06-07 | ノロウイルスに対して防御免疫応答を付与する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525114A Pending JP2010539192A (ja) | 2007-09-18 | 2008-09-18 | ノロウイルスに対して防御免疫応答を付与する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016149168A Active JP6615063B2 (ja) | 2007-09-18 | 2016-07-29 | ノロウイルスに対して防御免疫応答を付与する方法 |
| JP2019107207A Withdrawn JP2019163328A (ja) | 2007-09-18 | 2019-06-07 | ノロウイルスに対して防御免疫応答を付与する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US10130696B2 (https=) |
| EP (1) | EP2190471A4 (https=) |
| JP (4) | JP2010539192A (https=) |
| KR (2) | KR20150129042A (https=) |
| CN (2) | CN104740624B (https=) |
| AU (1) | AU2008302276B2 (https=) |
| CA (1) | CA2698397C (https=) |
| SG (2) | SG10201601660YA (https=) |
| WO (1) | WO2009039229A2 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2066354B1 (en) | 2006-09-29 | 2013-04-17 | Ligocyte Pharmaceuticals, Inc. | Norovirus vaccine formulations |
| WO2008113011A2 (en) | 2007-03-14 | 2008-09-18 | Ligocyte Pharmaceuticals, Inc. | Virus like particle purification |
| US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
| CN104740624B (zh) | 2007-09-18 | 2018-04-24 | 武田疫苗股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
| NO2324113T3 (https=) | 2008-08-08 | 2018-07-28 | ||
| US20120121710A1 (en) | 2009-03-27 | 2012-05-17 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Mucosal Immunization |
| JP5804453B2 (ja) * | 2009-05-14 | 2015-11-04 | 国立大学法人 東京大学 | 結晶性ポリオール微粒子及びその調製方法 |
| WO2011079260A2 (en) * | 2009-12-23 | 2011-06-30 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Stabilized virus like particles having enhanced mucosal immunogenicity |
| AU2011276328C1 (en) * | 2010-07-06 | 2016-01-21 | Novartis Ag | Norovirus derived immunogenic compositions and methods |
| FI122520B (fi) * | 2010-10-15 | 2012-03-15 | Vesna Blazevic | Noroviruksen kapsidi ja rotaviruksen VP6-proteiini käytettäväksi yhdistelmärokotteena |
| JP6309274B2 (ja) * | 2011-03-11 | 2018-04-11 | ターンストーン・リミテッド・パートナーシップ | ヒストンデアセチラーゼ阻害剤を含むワクチン接種法 |
| EP4112074A1 (en) * | 2011-07-11 | 2023-01-04 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
| CA2851917A1 (en) * | 2011-10-12 | 2013-04-18 | Alpha-O Peptides Ag | Self-assembling peptide nanoparticles as vaccines against infection with norovirus |
| CN102559616B (zh) * | 2012-02-24 | 2014-01-01 | 河南科技大学 | 一种含诺如病毒rna片段的假病毒颗粒及其制备方法 |
| CN110064049B (zh) | 2012-06-21 | 2024-02-09 | 西北大学 | 肽缀合粒子 |
| JOP20130186B1 (ar) * | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| JP2015017065A (ja) * | 2013-07-12 | 2015-01-29 | 株式会社Umnファーマ | ノロウイルスのウイルス様粒子を含む医薬組成物 |
| US20150086592A1 (en) * | 2013-09-25 | 2015-03-26 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| CN106103720A (zh) | 2013-10-03 | 2016-11-09 | 武田疫苗股份有限公司 | 自细胞系检测和除去弹状病毒的方法 |
| US20160310412A1 (en) | 2013-12-16 | 2016-10-27 | Takeda Pharmaceutical Company Limited | Microneedle |
| EP3116479A1 (en) * | 2014-03-12 | 2017-01-18 | GlaxoSmithKline Biologicals S.A. | Liposomal compositions for mucosal delivery |
| US20180243397A1 (en) | 2015-08-28 | 2018-08-30 | Ron Cobb | Norovirus vaccine |
| JP6977206B2 (ja) * | 2016-03-31 | 2021-12-08 | 富山県 | 自然免疫を活性化する粘膜ワクチン用アジュバント |
| CN107184970A (zh) * | 2017-02-16 | 2017-09-22 | 北京生物制品研究所有限责任公司 | 口服诺如病毒亚单位疫苗及lt作为该疫苗佐剂的用途 |
| US11633467B2 (en) | 2018-02-15 | 2023-04-25 | Icon Genetics Gmbh | Immunogenic composition and vaccine for generating an immune response to norovirus |
| US20210308249A1 (en) * | 2018-08-20 | 2021-10-07 | Takeda Vaccines, Inc. | Vlp formulations |
| AR117462A1 (es) * | 2018-12-20 | 2021-08-04 | Takeda Vaccines Inc | Vacuna contra norovirus, formulaciones y métodos |
| US20240238401A1 (en) | 2021-05-21 | 2024-07-18 | Takeda Vaccines, Inc. | Solid composition, freeze-drying method and glass vial |
| CN115677838A (zh) * | 2021-07-29 | 2023-02-03 | 成都康华生物制品股份有限公司 | 六价诺如病毒VLPs疫苗及其制备方法 |
| WO2023176206A1 (ja) | 2022-03-18 | 2023-09-21 | デンカ株式会社 | リンカーにより連結されたカプシドタンパク質を含むウイルス様粒子 |
| WO2025076792A1 (en) * | 2023-10-12 | 2025-04-17 | Chengdu Kanghua Biological Product Co., Ltd. | Methods of preparing norovirus vaccine with low amounts of adjuvant |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6572862B1 (en) | 1989-11-08 | 2003-06-03 | Baylor College Of Medicine | Methods and reagents to detect and characterize Norwalk and related viruses |
| AU1893592A (en) | 1991-03-25 | 1992-10-21 | Board Of Trustees Of The Leland Stanford Junior University | Norwalk virus human gastroenteritis agent and molecular cloning of corresponding cdnas |
| EP0635056A1 (en) | 1992-04-08 | 1995-01-25 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| US5788970A (en) | 1994-03-29 | 1998-08-04 | The University Of Maryland College Park | Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon |
| ATE328068T1 (de) | 1994-05-16 | 2006-06-15 | Merck & Co Inc | Papillomavirus vakzine |
| US5645051A (en) | 1995-04-21 | 1997-07-08 | Dura Pharmaceuticals, Inc. | Unit dose dry powder inhaler |
| US5861241A (en) | 1995-08-16 | 1999-01-19 | University Of Massachusetts | Monoclonal antibodies for detecting Norwalk virus |
| GB9525083D0 (en) | 1995-12-07 | 1996-02-07 | Danbiosyst Uk | Vaccine compositions |
| US5834015A (en) | 1996-09-11 | 1998-11-10 | Albany Medical College | Protein-lipid vesicles and autogenous vaccine comprising the same |
| US5953727A (en) | 1996-10-10 | 1999-09-14 | Incyte Pharmaceuticals, Inc. | Project-based full-length biomolecular sequence database |
| US6491919B2 (en) | 1997-04-01 | 2002-12-10 | Corixa Corporation | Aqueous immunologic adjuvant compostions of monophosphoryl lipid A |
| PT973546E (pt) | 1997-04-08 | 2004-06-30 | Merck & Co Inc | Formulacoes estabilizadas de virus de papiloma humano |
| AU750702B2 (en) | 1997-05-01 | 2002-07-25 | Chiron Corporation | Use of virus-like particles as adjuvants |
| US20040265377A1 (en) | 1997-10-27 | 2004-12-30 | Harry Seager | Solid dispersing vaccine composition for oral delivery |
| HUP0103091A3 (en) | 1998-08-14 | 2002-03-28 | Merck & Co Inc | Process for purifying human papillomavirus virus-like particles |
| WO2000035479A1 (en) | 1998-12-17 | 2000-06-22 | Merck & Co., Inc. | Synthetic virus-like particles with heterologous epitopes |
| AU764138B2 (en) | 1999-02-05 | 2003-08-14 | Merck Sharp & Dohme Corp. | Human papilloma virus vaccine formulations |
| KR100771402B1 (ko) | 1999-06-22 | 2007-10-30 | 국립감염증연구소장이 대표하는 일본국 | Srsv 검출 킷트 |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| US20040121465A1 (en) | 2002-02-14 | 2004-06-24 | Novavax, Inc. | Optimization of gene sequences of virus-like particles for expression in insect cells |
| GB0206359D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| WO2003087327A2 (en) | 2002-04-11 | 2003-10-23 | Medimmune Vaccines, Inc. | Preservation of bioactive materials by freeze dried foam |
| GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| JP2006507800A (ja) | 2002-06-07 | 2006-03-09 | ラージ・スケール・バイオロジー・コーポレイション | 可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム |
| BR0311995A (pt) | 2002-06-20 | 2005-04-05 | Cytos Biotechnology Ag | Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso |
| CA2514667C (en) | 2003-01-30 | 2013-01-08 | Chiron Corporation | Adjuvanted influenza vaccine |
| US20040213745A1 (en) | 2003-02-20 | 2004-10-28 | Vincent Sullivan | Powder formulations of rSEB for improved vaccination |
| US8592197B2 (en) | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
| WO2005032457A2 (en) | 2003-07-21 | 2005-04-14 | Boyce Thompson Institute For Plant Research, Inc. | Vectors and methods for immunization against norwalk virus using transgenic plants |
| JP2007537137A (ja) | 2003-09-24 | 2007-12-20 | モンタナ ステート ユニバーシティ | ノロウィルスモノクローナル抗体及びペプチド |
| WO2005037223A2 (en) | 2003-10-15 | 2005-04-28 | Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
| US20050215501A1 (en) | 2003-10-24 | 2005-09-29 | Coley Pharmaceutical Group, Inc. | Methods and products for enhancing epitope spreading |
| FR2863890B1 (fr) | 2003-12-19 | 2006-03-24 | Aventis Pasteur | Composition immunostimulante |
| US7481997B1 (en) | 2004-02-12 | 2009-01-27 | Montana State University | Snow mountain virus genome sequence, virus-like particles and methods of use |
| US20050260225A1 (en) | 2004-05-18 | 2005-11-24 | Goldberg Joanna B | Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens |
| CU23496A1 (es) | 2004-09-03 | 2010-02-23 | Ct Ingenieria Genetica Biotech | Composición vacunal contra el virus de la hepatitis c |
| SG156666A1 (en) | 2004-10-20 | 2009-11-26 | Acambis Inc | Vaccines against japanese encephalitis virus and west nile virus |
| GB0428394D0 (en) | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
| US20060177468A1 (en) | 2005-01-05 | 2006-08-10 | Philadelphia Health and Education Corporation (d/b/a Drexel University College of Medicine | Delivery vehicles, bioactive substances and viral vaccines |
| EP1846439A2 (en) | 2005-01-31 | 2007-10-24 | The Johns Hopkins University | Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants |
| JP2008530245A (ja) | 2005-02-18 | 2008-08-07 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | 尿路病原性菌株由来の抗原 |
| ZA200707413B (en) | 2005-03-18 | 2009-01-28 | Cytos Biotechnology Ag | Cat allergen fusion proteins and uses thereof |
| BRPI0611336A2 (pt) | 2005-06-01 | 2010-08-31 | Dow Global Technologies Inc | método para produzir uma partìcula multivalente semelhante a vìrus, partìcula multivalente semelhante a vìrus, método de aumentar a solubilidade de uma partìcula multivalente semelhante a vìrus e vacina |
| EP1736538A1 (en) | 2005-06-21 | 2006-12-27 | Cytos Biotechnology AG | Process for the preparative purification of virus-like-particles (VLPs) |
| ES2514316T3 (es) | 2005-11-22 | 2014-10-28 | Novartis Vaccines And Diagnostics, Inc. | Partículas similares a virus (VLPs) de Norovirus y Sapovirus |
| JP2007145775A (ja) | 2005-11-29 | 2007-06-14 | Falco Life Science:Kk | ノロウイルスgiの高感度検出方法 |
| EP2066354B1 (en) | 2006-09-29 | 2013-04-17 | Ligocyte Pharmaceuticals, Inc. | Norovirus vaccine formulations |
| PT2121011E (pt) | 2006-12-06 | 2014-07-31 | Novartis Ag | Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe |
| WO2008113011A2 (en) | 2007-03-14 | 2008-09-18 | Ligocyte Pharmaceuticals, Inc. | Virus like particle purification |
| CN104740624B (zh) | 2007-09-18 | 2018-04-24 | 武田疫苗股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
| US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
| NO2324113T3 (https=) | 2008-08-08 | 2018-07-28 | ||
| WO2010084298A1 (en) | 2009-01-22 | 2010-07-29 | Pharmathene Uk Limited | Stable vaccine compositions and methods of use |
| EA201171032A1 (ru) | 2009-02-10 | 2012-02-28 | Новартис Аг | Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами |
| US20110070260A1 (en) | 2009-09-09 | 2011-03-24 | Baric Ralph S | Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use |
| CA2787666A1 (en) | 2010-01-21 | 2011-07-28 | Ligocyte Pharmaceuticals, Inc. | Targeted heterologous antigen presentation on calicivirus virus-like particles |
| CA2798739A1 (en) | 2010-05-26 | 2011-12-01 | Selecta Biosciences, Inc. | Nanocarrier compositions with uncoupled adjuvant |
| EP4112074A1 (en) | 2011-07-11 | 2023-01-04 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
| JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| EP3827838B1 (en) | 2015-12-16 | 2023-06-07 | The Walter and Eliza Hall Institute of Medical Research | Inhibition of cytokine-induced sh2 protein in nk cells |
| CN110520530A (zh) | 2016-10-18 | 2019-11-29 | 明尼苏达大学董事会 | 肿瘤浸润性淋巴细胞和治疗方法 |
| KR20210005240A (ko) | 2018-05-03 | 2021-01-13 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 면역 관문 차단과 함께 키메라 항원 수용체를 발현하도록 가공된 천연 킬러 세포 |
| US20210308249A1 (en) | 2018-08-20 | 2021-10-07 | Takeda Vaccines, Inc. | Vlp formulations |
| AR117462A1 (es) | 2018-12-20 | 2021-08-04 | Takeda Vaccines Inc | Vacuna contra norovirus, formulaciones y métodos |
| PE20211959A1 (es) | 2019-02-15 | 2021-09-30 | Editas Medicine Inc | Celulas asesinas naturales (nk) modificadas para inmunoterapia |
-
2008
- 2008-09-18 CN CN201410764410.3A patent/CN104740624B/zh active Active
- 2008-09-18 KR KR1020157030824A patent/KR20150129042A/ko not_active Ceased
- 2008-09-18 KR KR1020107008312A patent/KR20100083150A/ko not_active Ceased
- 2008-09-18 CA CA2698397A patent/CA2698397C/en active Active
- 2008-09-18 AU AU2008302276A patent/AU2008302276B2/en not_active Ceased
- 2008-09-18 JP JP2010525114A patent/JP2010539192A/ja active Pending
- 2008-09-18 US US12/678,813 patent/US10130696B2/en active Active
- 2008-09-18 WO PCT/US2008/076763 patent/WO2009039229A2/en not_active Ceased
- 2008-09-18 CN CN200880116659.6A patent/CN101918028B/zh active Active
- 2008-09-18 EP EP08832560A patent/EP2190471A4/en not_active Withdrawn
- 2008-09-18 SG SG10201601660YA patent/SG10201601660YA/en unknown
- 2008-09-18 SG SG2012066726A patent/SG184733A1/en unknown
-
2014
- 2014-05-02 JP JP2014095094A patent/JP6296885B2/ja active Active
-
2016
- 2016-07-29 JP JP2016149168A patent/JP6615063B2/ja active Active
-
2019
- 2019-06-03 US US16/429,580 patent/US10688174B2/en active Active
- 2019-06-07 JP JP2019107207A patent/JP2019163328A/ja not_active Withdrawn
-
2020
- 2020-05-08 US US16/870,020 patent/US11040097B2/en active Active
-
2021
- 2021-06-15 US US17/348,045 patent/US11826415B2/en active Active
-
2023
- 2023-10-19 US US18/490,157 patent/US20240316175A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014141528A5 (https=) | ||
| JP2010539192A5 (https=) | ||
| JP2016020378A5 (https=) | ||
| Riese et al. | Vaccine adjuvants: key tools for innovative vaccine design | |
| JP5650780B2 (ja) | ワクチン組成物 | |
| JP2011530295A5 (https=) | ||
| US20180169223A1 (en) | Vaccine adjuvant composition comprising inulin particles | |
| Alving et al. | Adjuvants for human vaccines | |
| Jabbal-Gill | Nasal vaccine innovation | |
| Hafner et al. | Particulate formulations for the delivery of poly (I: C) as vaccine adjuvant | |
| JP2009511084A5 (https=) | ||
| Barjesteh et al. | Reduction of avian influenza virus shedding by administration of Toll-like receptor ligands to chickens | |
| Dehghan et al. | Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants | |
| RU2011122418A (ru) | Иммуностимулирующие олигонуклеотиды | |
| WO2009039229A3 (en) | Method of conferring a protective immune response to norovirus | |
| JP2004527264A5 (https=) | ||
| NO20074638L (no) | Ny sammensetning | |
| US10857228B2 (en) | Adjuvant for vaccines, vaccine, and immunity induction method | |
| JP2011515490A5 (https=) | ||
| JP2018500322A5 (https=) | ||
| Jones et al. | Protollin™: a novel adjuvant for intranasal vaccines | |
| AU2012211043B2 (en) | Combination vaccines | |
| JP2009541281A (ja) | キチンマイクロ粒子を含む組成物およびそれらの医学的使用 | |
| JP2016529316A5 (https=) | ||
| JP2010501595A5 (https=) |